[VRAX] YoY Annual Result on 31-Mar-2022 [#FY]

Stock
[VRAX] Virax Biolabs Group Limited
Announcement Date
12-Aug-2022
Financial Year
2022
Quarter
31-Mar-2022 [#FY]
Profit Trend
YoY- -162.52%
Quarter Report
VRAX's Result
VRAX's Financial Summary
View:
Show?
Annual Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 156 9 0 124 100 11.75%
PBT -6,739 -5,458 -1,750 -673 -739 73.70%
Tax -194 -0 -1,775 -666 62 -
NP -6,734 -5,457 -1,709 -651 -801 70.21%
Tax Rate - - - - - -
Total Cost 6,890 5,466 1,709 775 901 66.23%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin -4,304.81 -63,748.32 0.00 -525.75 -802.13 52.16%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -3.79 -5.13 -1.50 -0.57 -0.70 52.49%
EPS Diluted -3.79 -5.13 -1.50 -0.57 -0.70 52.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.